Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Oct 23, 2023 8:31pm
182 Views
Post# 35697402

RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE FinancingI imagine this is the last cash raise they'll need. I still think they have a jv interested, probably for GBM, and it should fund them in all of their efforts to a few years. Should get the 50cent January warrants to come in, and eventually the Aug warrants. Along with jv front cash that is another $20Mil C. They'll be fine to either do a jv on nmibc or have a strong buyout negotiation.  IMO.. I'm betting the GBM partner is that long forgotten CanCanibis company. They will do the heavy lifting to get TLT into solid tumor trials.
<< Previous
Bullboard Posts
Next >>